菜单

Supply Chain Intelligence about:

Sanofi

企业页面   France

See Sanofi's products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

72美国进口货运
US
15 南美货运信息
南美

以公司为组织的美国海关记录

72 U.S. shipments available for Sanofi, updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2022-04-21 Sanofi
Sds Wf
X XXXXXXXXXXX XXXXXXXXXXXX XXXXXXXX XXXX XX XXXXXXX XXXXXX XX XX XXX XX X XXXXXX XXXXXX XXXXXXXXX XXXX XXXXXXXXX XXXXXX XXXXXX XX XX XX XX XXXXXXX XXXX X XXXX XXXXXX XX X X XXX XXX XXXXXXXX XXXXX XXXXXXXXXX XXXXXXXX XXXXXXXXXXXX XXXXXXX XXXXXXX
货运提单
2022-03-05 Sanofi
Sanofi Pasteur SA De Cv
XXXXXXX XXXXXXX XXX XXXXX XXXXXXXX XXXXXX XXXXXXXXXX XXX XXXXXXXXXXXXXX XXXXXXXXX
货运提单
2021-03-02 Sanofi
Sanofi Pasteur Y O Absolute
XXXXX XXXXXXXX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data

Contact information for Sanofi

 
地址
7 RUE DES GENETS SAINT LOUBES FR
 
 

Sample Bill of Lading

264 shipment records available

Date
2022-04-21
Shipper Name
Sanofi
Shipper Address
9 RUE SALVADOR AL GENTILLY FR
Consignee Name
Sds Wf
Consignee Address
063/PHARM/22 MATA UTU WF
Weight
207
Weight Unit
KG
Weight in KG
207.0
Quantity
37
Quantity Unit
PKG
Measure Unit
CM
Shipment Origin
France
Details
207.0 kg
From port: Le Havre, France
To port: New York/Newark Area, Newark, New Jersey
Place of Receipt
Le Havre
Foreign Port of Lading
Le Havre, France
U.S. Port of Unlading
New York/Newark Area, Newark, New Jersey
U.S. Destination Port
New York/Newark Area, Newark, New Jersey
Commodity
X XXXXXXXXXXX XXXXXXXXXXXX XXXXXXXX XXXX XX XXXXXXX XXXXXX XX XX XXX XX X XXXXXX XXXXXX XXXXXXXXX XXXX XXXXXXXXX XXXXXX XXXXXX XX XX XX XX XXXXXXX XXXX X XXXX XXXXXX XX X X XXX XXX XXXXXXXX XXXXX XXXXXXXXXX XXXXXXXX XXXXXXXXXXXX XXXXXXX XXXXXXX
Container
GESU1202382
Carrier Name
CMA-CGM
Vessel Name
SEATRADE RED
Voyage Number
0RPA9
Bill of Lading Number
CMDUFR40298513
Master Bill of Lading Number
CMDULHV2807563
Lloyd's Code
9690107
HTS Codes
HTS 3004.90

Recent Panjiva Research about Sanofi

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →